These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1160 related articles for article (PubMed ID: 30246429)
41. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells. Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447 [TBL] [Abstract][Full Text] [Related]
42. The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter. Gan L; Xu M; Hua R; Tan C; Zhang J; Gong Y; Wu Z; Weng W; Sheng W; Guo W J Hematol Oncol; 2018 Jan; 11(1):9. PubMed ID: 29335012 [TBL] [Abstract][Full Text] [Related]
43. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway. Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938 [TBL] [Abstract][Full Text] [Related]
44. Overexpression of Circular RNA ciRS-7 Abrogates the Tumor Suppressive Effect of miR-7 on Gastric Cancer via PTEN/PI3K/AKT Signaling Pathway. Pan H; Li T; Jiang Y; Pan C; Ding Y; Huang Z; Yu H; Kong D J Cell Biochem; 2018 Jan; 119(1):440-446. PubMed ID: 28608528 [TBL] [Abstract][Full Text] [Related]
45. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway. Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814 [TBL] [Abstract][Full Text] [Related]
46. Thidiazuron suppresses breast cancer via targeting miR-132 and dysregulation of the PI3K-Akt signaling pathway mediated by the miR-202-5p-PTEN axis. Ibrahim HM; Ismail MB; Ammar RB; Ahmed EA Biochem Cell Biol; 2021 Jun; 99(3):374-384. PubMed ID: 33103467 [TBL] [Abstract][Full Text] [Related]
47. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway. Li L; Zhu X; Shou T; Yang L; Cheng X; Wang J; Deng L; Zheng Y Mol Med Rep; 2018 Mar; 17(3):4003-4010. PubMed ID: 29257342 [TBL] [Abstract][Full Text] [Related]
48. TRIM14 promotes the migration and invasion of gastric cancer by regulating epithelial‑to‑mesenchymal transition via activation of AKT signaling regulated by miR‑195‑5p. Wang F; Ruan L; Yang J; Zhao Q; Wei W Oncol Rep; 2018 Dec; 40(6):3273-3284. PubMed ID: 30272351 [TBL] [Abstract][Full Text] [Related]
49. XB130 promotes proliferation and invasion of gastric cancer cells. Shi M; Zheng D; Sun L; Wang L; Lin L; Wu Y; Zhou M; Liao W; Liao Y; Zuo Q; Liao W J Transl Med; 2014 Jan; 12():1. PubMed ID: 24387290 [TBL] [Abstract][Full Text] [Related]
50. Positive feedback loop of FAM83A/PI3K/AKT/c-Jun induces migration, invasion and metastasis in hepatocellular carcinoma. Liu C; Peng X; Li Y; Liu S; Hou R; Zhang Y; Zuo S; Liu Z; Luo R; Li L; Fang W Biomed Pharmacother; 2020 Mar; 123():109780. PubMed ID: 31901550 [TBL] [Abstract][Full Text] [Related]
51. Total flavonoids from Smilax glabra Roxb blocks epithelial-mesenchymal transition and inhibits renal interstitial fibrosis by targeting miR-21/PTEN signaling. Luo Q; Cai Z; Tu J; Ling Y; Wang D; Cai Y J Cell Biochem; 2019 Mar; 120(3):3861-3873. PubMed ID: 30304552 [TBL] [Abstract][Full Text] [Related]
52. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer. Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547 [TBL] [Abstract][Full Text] [Related]
53. MiR-592 Promotes Gastric Cancer Proliferation, Migration, and Invasion Through the PI3K/AKT and MAPK/ERK Signaling Pathways by Targeting Spry2. He Y; Ge Y; Jiang M; Zhou J; Luo D; Fan H; Shi L; Lin L; Yang L Cell Physiol Biochem; 2018; 47(4):1465-1481. PubMed ID: 29949784 [TBL] [Abstract][Full Text] [Related]
54. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220 [TBL] [Abstract][Full Text] [Related]
55. Tensin4 promotes invasion and migration of gastric cancer cells via regulating AKT/GSK-3β/snail signaling pathway. Qi X; Sun L; Wan J; Xu R; He S; Zhu X Pathol Res Pract; 2020 Jul; 216(7):153001. PubMed ID: 32534709 [TBL] [Abstract][Full Text] [Related]
56. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
57. LINC00511 promotes gastric cancer progression by regulating SOX4 and epigenetically repressing PTEN to activate PI3K/AKT pathway. Wang Q; Mao X; Luo F; Wang J J Cell Mol Med; 2021 Oct; 25(19):9112-9127. PubMed ID: 34427967 [TBL] [Abstract][Full Text] [Related]
58. WSTF promotes proliferation and invasion of lung cancer cells by inducing EMT via PI3K/Akt and IL-6/STAT3 signaling pathways. Meng J; Zhang XT; Liu XL; Fan L; Li C; Sun Y; Liang XH; Wang JB; Mei QB; Zhang F; Zhang T Cell Signal; 2016 Nov; 28(11):1673-82. PubMed ID: 27449264 [TBL] [Abstract][Full Text] [Related]
59. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB. Zhao H; Xu J; Wang Y; Jiang R; Li X; Zhang L; Che Y Surg Oncol; 2018 Sep; 27(3):495-502. PubMed ID: 30217308 [TBL] [Abstract][Full Text] [Related]
60. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways. Dong F; Liu T; Jin H; Wang W Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]